Suspected Congo Ebola victims test negative for the virus | Why a pandemic flu shot caused narcolepsy | Infectious disease: The coolest specialty in the world | California legislators approve strict school vaccine bill | Liberia’s puzzle: How did the new Ebola patient become infected? | After years of wait, C-123 vets to get VA benefits for Agent Orange exposure | GSK upgrade delays supply of adjuvanted H5N1 vaccine | Monitoring exposure of U.S. military personnel deployed for Ebola efforts | Treating Ebola virus with generic statins and angiotensin receptor blockers | First confirmed U.S. measles death in more than a decade | ECBC scientists testing fabric for new warfighter uniforms | Taking aim at Ebola: Team B’s target profile defines vaccine requirements | New York preparedness teams planning for arrival of avian flu | Ebola virus: wild and domestic animals, plants and insects | New antibody discovery holds promise for dengue vaccine | Spotlight: LVAP method for protective equipment | New study could help bio-threat response | Superbug threat prompts West to revisit Soviet-era virus therapy | New salmonella tracker now available to pathogen investigators | Limiting rights in the context of Ebola and other public health emergencies | Organ-on-chip could revolutionize drug testing | Washington state reports first U.S. measles death in 12 years | Liberia: 200 reportedly had contact with Ebola victim | Adapting the mobile laboratory to the changing needs of the Ebola epidemic | Be prepared: Europe needs Ebola outbreak consortium
See what we’re reading this week at Global Biodefense on topics including reappearance of Ebola in Liberia, flu shots and narcolepsy, measles death in the U.S. and more…
Suspected Congo Ebola victims test negative for the virus (Reuters)
Why a pandemic flu shot caused narcolepsy (Science Insider)
Infectious disease: The coolest specialty in the world (Tracking Zebra)
California legislators approve strict school vaccine bill (Orlando Sentinel)
Liberia’s puzzle: How did the new Ebola patient become infected? (Science Insider)
GSK upgrade delays supply of adjuvanted H5N1 vaccine (CIDRAP)
Monitoring exposure of U.S. military personnel deployed for Ebola efforts (CDC)
Treating Ebola virus with generic statins and angiotensin receptor blockers (mBio)
First confirmed U.S. measles death in more than a decade (Forbes)
ECBC scientists testing fabric for new warfighter uniforms (ECBC)
Taking aim at Ebola: Team B’s target profile defines vaccine requirements (CIDRAP)
New York preparedness teams planning for arrival of avian flu (Emergency Management)
Ebola virus: wild and domestic animals, plants and insects (Virology Down Under)
New antibody discovery holds promise for dengue vaccine (MNT)
New study could help bio-threat response (FCW)
Superbug threat prompts West to revisit Soviet-era virus therapy (Reuters)
Limiting rights in the context of Ebola and other public health emergencies (HHR Journal)
Organ-on-chip could revolutionize drug testing (Newsweek)
Washington state reports first U.S. measles death in 12 years (Reuters)
Liberia: 200 reportedly had contact with Ebola victim (NY Times)
Be prepared: Europe needs Ebola outbreak consortium (Nature)
